Chief, Division of Hematologic Malignancies & Cellular Therapy
The Department of Medicine and the Duke Cancer Institute at Duke Health in Durham, North Carolina, are seeking candidates for Chief of the Division of Hematologic Malignancies & Cellular Therapy. This is an excellent opportunity to lead an outstanding division of researchers, educators, and clinicians; interact with robust clinical and research programs at Duke in all facets of hematologic oncology and cellular therapy; and complement Duke’s exceptional medical oncology and non-malignant hematology divisions. Candidates will have demonstrated a high level of administrative, clinical, and research experience and competence and be able to provide outstanding leadership of the clinical, research, and training missions of the division and the Duke Cancer Institute.
Applicants for this position should be eligible for appointment at the Associate Professor level or higher (tenure track) at Duke University School of Medicine. Additional information about the Department of Medicine, Division of Hematologic Malignancies & Cellular Therapy, and Duke Cancer Institute is posted at http://medicine.duke.edu and http://www.dukecancerinstitute.org/. Qualified individuals should send a letter of interest describing their clinical, research, and administrative experience and expertise, along with a current curriculum vitae, to HMCTchiefsearch@dm.duke.edu
by December 1, 2019
Duke University is an Affirmative Action and Equal Opportunity Employer. Women and minorities are encouraged to apply.
As a world-class academic and health care system, Duke strives to transform medicine and health locally and globally through innovative scientific research, rapid translation of breakthrough discoveries, educating future clinical and scientific leaders, advocating and practicing evidence-based medicine to improve community health, and leading efforts to eliminate health inequalities.